BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yuksel M, Okajima K, Uchiba M, Okabe H. Gabexate mesilate, a synthetic protease inhibitor, inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production by inhibiting activation of both nuclear factor-kappaB and activator protein-1 in human monocytes. J Pharmacol Exp Ther. 2003;305:298-305. [PMID: 12649382 DOI: 10.1124/jpet.102.041988] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Hidaka S, Iwasaka H, Hagiwara S, Noguchi T. Gabexate mesilate inhibits the expression of HMGB1 in lipopolysaccharide-induced acute lung injury. J Surg Res. 2011;165:142-150. [PMID: 19766246 DOI: 10.1016/j.jss.2009.05.039] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
2 Tumurkhuu G, Koide N, Hiwasa T, Ookoshi M, Dagvadorj J, Abu Shadat Mohammod Noman, Iftakhar-E-Khuda I, Naiki Y, Komatsu T, Yoshida T, Yokochi T. ONO 3403, a synthetic serine protease inhibitor, inhibits lipopolysaccharide-induced tumor necrosis factor-{alpha} and nitric oxide production and protects mice from lethal endotoxic shock. Innate Immun 2011;17:97-105. [PMID: 20023007 DOI: 10.1177/1753425909353641] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
3 Ramadass V, Vaiyapuri T, Tergaonkar V. Small Molecule NF-κB Pathway Inhibitors in Clinic. Int J Mol Sci 2020;21:E5164. [PMID: 32708302 DOI: 10.3390/ijms21145164] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 22.0] [Reference Citation Analysis]
4 Li K, Fan J, Qin X, Wei Q. Novel therapeutic compounds for prostate adenocarcinoma treatment: An analysis using bioinformatic approaches and the CMap database. Medicine (Baltimore) 2020;99:e23768. [PMID: 33371142 DOI: 10.1097/MD.0000000000023768] [Reference Citation Analysis]
5 Tsai HJ, Ding C, Tsao CM, Liao MH, Ka SM, Liaw WJ, Wu CC. Effects of gabexate mesilate on coagulopathy and organ dysfunction in rats with endotoxemia: a potential use of thrombelastography in endotoxin-induced sepsis. Blood Coagul Fibrinolysis 2015;26:175-84. [PMID: 25396762 DOI: 10.1097/MBC.0000000000000214] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
6 Ledgerwood AM, Blaisdell W. Coagulation challenges after severe injury with hemorrhagic shock. J Trauma Acute Care Surg 2012;72:1714-8. [PMID: 22695446 DOI: 10.1097/TA.0b013e318245225c] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
7 Hu X, Shrimp JH, Guo H, Xu M, Chen CZ, Zhu W, Zakharov A, Jain S, Shinn P, Simeonov A, Hall MD, Shen M. Discovery of TMPRSS2 inhibitors from virtual screening. bioRxiv 2021:2020. [PMID: 33398276 DOI: 10.1101/2020.12.28.424413] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Ueno C, Fukatsu K, Kang W, Maeshima Y, Moriya T, Hara E, Nagayoshi H, Omata J, Saito H, Hiraide H, Mochizuki H. Route and type of nutrition influence nuclear factor kappaB activation in peritoneal resident cells. Shock 2005;24:382-7. [PMID: 16205325 DOI: 10.1097/01.shk.0000180623.29188.3b] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
9 Ueno C, Fukatsu K, Kang W, Maeshima Y, Nagayoshi H, Omata J, Saito H, Hiraide H, Mochizuki H. Lack of Enteral Nutrition Delays Nuclear Factor Kappa B Activation in Peritoneal Exudative Cells in a Murine Glycogen-Induced Peritonitis Model. JPEN J Parenter Enteral Nutr 2017;30:179-85. [DOI: 10.1177/0148607106030003179] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
10 Gibo J, Ito T, Kawabe K, Hisano T, Inoue M, Fujimori N, Oono T, Arita Y, Nawata H. Camostat mesilate attenuates pancreatic fibrosis via inhibition of monocytes and pancreatic stellate cells activity. Lab Invest. 2005;85:75-89. [PMID: 15531908 DOI: 10.1038/labinvest.3700203] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 3.4] [Reference Citation Analysis]
11 Huang XL, Ling YL, Ling YQ, Zhou JL, Liu Y, Wang QH. Heme oxygenase-1 in cholecystokinin-octapeptipe attenuated injury of pulmonary artery smooth muscle cells induced by lipopolysaccharide and its signal transduction mechanism. World J Gastroenterol. 2004;10:1789-1794. [PMID: 15188507 DOI: 10.3748/wjg.v10.i12.1789] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
12 Imberti R, Ferrigno A, Tartaglia A, Rizzo V, Richelmi P, Vairetti M. Changes in extra- and intracellular pH in hepatocytes exposed to gabexate mesilate. Int J Immunopathol Pharmacol 2014;27:365-70. [PMID: 25280027 DOI: 10.1177/039463201402700306] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
13 Bulfone TC, Samuel SP, Bickler PE, Lewin MR. Developing Small Molecule Therapeutics for the Initial and Adjunctive Treatment of Snakebite. J Trop Med 2018;2018:4320175. [PMID: 30154870 DOI: 10.1155/2018/4320175] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 8.3] [Reference Citation Analysis]
14 Yoshikawa S, Tsushima K, Koizumi T, Kubo K. Effects of a synthetic protease inhibitor (gabexate mesilate) and a neutrophil elastase inhibitor (sivelestat sodium) on acid-induced lung injury in rats. Eur J Pharmacol 2010;641:220-5. [PMID: 20542026 DOI: 10.1016/j.ejphar.2010.05.039] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
15 Martin L, Pingle SC, Hallam DM, Rybak LP, Ramkumar V. Activation of the adenosine A3 receptor in RAW 264.7 cells inhibits lipopolysaccharide-stimulated tumor necrosis factor-alpha release by reducing calcium-dependent activation of nuclear factor-kappaB and extracellular signal-regulated kinase 1/2. J Pharmacol Exp Ther 2006;316:71-8. [PMID: 16188954 DOI: 10.1124/jpet.105.091868] [Cited by in Crossref: 86] [Cited by in F6Publishing: 82] [Article Influence: 5.4] [Reference Citation Analysis]
16 Neumann I, Grassi B, Bdair F, Rada G; Cochrane Upper GI and Pancreatic Diseases Group. Antiproteases for acute pancreatitis. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd009426] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
17 Ueno C, Fukatsu K, Maeshima Y, Moriya T, Omata J, Saitoh D, Mochizuki H. Arginine-enriched total parenteral nutrition improves survival in peritonitis by normalizing NFkappaB activation in peritoneal resident and exudative leukocytes. Ann Surg 2010;251:959-65. [PMID: 20395852 DOI: 10.1097/SLA.0b013e3181d775ea] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
18 Hu X, Shrimp JH, Guo H, Xu M, Chen CZ, Zhu W, Zakharov AV, Jain S, Shinn P, Simeonov A, Hall MD, Shen M. Discovery of TMPRSS2 Inhibitors from Virtual Screening as a Potential Treatment of COVID-19. ACS Pharmacol Transl Sci 2021;4:1124-35. [PMID: 34136758 DOI: 10.1021/acsptsci.0c00221] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
19 Komura H, Uchiba M, Mizuochi Y, Arai M, Harada N, Katsuya H, Okajima K. Antithrombin inhibits lipopolysaccharide-induced tumor necrosis factor-α production by monocytes in vitro through inhibition of Egr-1 expression. J Thromb Haemost 2008;6:499-507. [DOI: 10.1111/j.1538-7836.2007.02869.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
20 Carlson CG, Samadi A, Siegel A. Chronic treatment with agents that stabilize cytosolic IkappaB-alpha enhances survival and improves resting membrane potential in MDX muscle fibers subjected to chronic passive stretch. Neurobiol Dis 2005;20:719-30. [PMID: 15955706 DOI: 10.1016/j.nbd.2005.05.003] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 2.1] [Reference Citation Analysis]
21 Mascolo A, Scavone C, Rafaniello C, Ferrajolo C, Racagni G, Berrino L, Paolisso G, Rossi F, Capuano A. Renin-Angiotensin System and Coronavirus Disease 2019: A Narrative Review. Front Cardiovasc Med 2020;7:143. [PMID: 32850989 DOI: 10.3389/fcvm.2020.00143] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
22 Arai M, Uchiba M, Komura H, Mizuochi Y, Harada N, Okajima K. Metformin, an antidiabetic agent, suppresses the production of tumor necrosis factor and tissue factor by inhibiting early growth response factor-1 expression in human monocytes in vitro. J Pharmacol Exp Ther. 2010;334:206-213. [PMID: 20371705 DOI: 10.1124/jpet.109.164970] [Cited by in Crossref: 75] [Cited by in F6Publishing: 71] [Article Influence: 6.8] [Reference Citation Analysis]
23 Chakraborti S, Bheemireddy S, Srinivasan N. Repurposing drugs against the main protease of SARS-CoV-2: mechanism-based insights supported by available laboratory and clinical data. Mol Omics 2020;16:474-91. [PMID: 32696772 DOI: 10.1039/d0mo00057d] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
24 Hagiwara S, Iwasaka H, Matumoto S, Noguchi T. Nafamostat mesilate inhibits high-mobility group box 1 by lipopolysaccharide stimulation in murine macrophage RAW 264.7. Shock 2007;27:429-35. [PMID: 17414427 DOI: 10.1097/01.shk.0000239778.25775.ad] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
25 Hattori Y, Hattori K, Suzuki T, Palikhe S, Matsuda N. Nucleic-acid based gene therapy approaches for sepsis. Eur J Pharmacol 2018;833:403-10. [PMID: 29935173 DOI: 10.1016/j.ejphar.2018.06.031] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
26 Molor-Erdene P, Okajima K, Isobe H, Uchiba M, Harada N, Okabe H. Urinary trypsin inhibitor reduces LPS-induced hypotension by suppressing tumor necrosis factor-alpha production through inhibition of Egr-1 expression. Am J Physiol Heart Circ Physiol. 2005;288:H1265-H1271. [PMID: 15539418 DOI: 10.1152/ajpheart.00885.2004] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
27 Hirai T, Matsumoto H, Kubota H, Yamaguchi Y. Regulating surgical oncotaxis to improve the outcomes in cancer patients. Surg Today 2014;44:804-11. [PMID: 23736890 DOI: 10.1007/s00595-013-0627-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
28 Catanzaro M, Fagiani F, Racchi M, Corsini E, Govoni S, Lanni C. Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2. Signal Transduct Target Ther 2020;5:84. [PMID: 32467561 DOI: 10.1038/s41392-020-0191-1] [Cited by in Crossref: 206] [Cited by in F6Publishing: 179] [Article Influence: 206.0] [Reference Citation Analysis]
29 Xu L, Sun J, Lu R, Ji Q, Xu JG. Effect of glutamate on inflammatory responses of intestine and brain after focal cerebral ischemia. World J Gastroenterol 2005;11:733-6. [PMID: 15655833 DOI: 10.3748/wjg.v11.i5.733] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
30 Potì F, Pozzoli C, Adami M, Poli E, Costa LG. Treatments for COVID-19: emerging drugs against the coronavirus. Acta Biomed 2020;91:118-36. [PMID: 32420936 DOI: 10.23750/abm.v91i2.9639] [Cited by in F6Publishing: 5] [Reference Citation Analysis]